News

PAREXEL has announced the acquisition of The Medical Affairs Company, a provider of outsourced medical affairs services to the pharma, biotech and medical device industries.

The temptation to use uncontrolled, early, small studies to support further development of products may prove problematic for emerging biopharma companies.

OmniComm Systems and MediStat have collaborated to expand their life sciences market presence in Israel.

Study finds that financial links between researchers and drug manufacturers are independently associated with positive trial results.

Q&A explores the evolution and challenges of new technology implementation in clinical trials.

Recent studies may help break down barriers to implementing patient-centric initiatives.

Reaching the point of seamless integration of patient-care options won't be easy, but you can visualize how to get there through the prism of the "Clinical Trial of Tomorrow/"

How the adoption of electronic clinical outcome assessment in trials can drive increased communication and patient reporting of events.

A look at the unique compliance and patient safety hurdles-and subsequent interventions-for resource-limited trial sites with no prior experience.

Highlighting the six broad technology themes poised to transform future R&D.

Click the title above to open the Applied Clinical Trials February/March 2017 issue in an interactive PDF format.

iCardiac Technologies has announced the launch of its Direct-to-Subject Pre-Coaching video tool.

The European Union effort to forge more cooperation among its national and regional HTA bodies is still a work in progress, as the process has produced varying views on the subject.

As part of its collaboration on type 2 diabetes with the University of Oxford in the U.K., Novo Nordisk is investing 1 billion Danish kroner over the next 10 years in a new research center.

PPD has announced the opening of a new clinical research unit for conducting Phase I and early development research in Las Vegas, Nevada.

With the new regulatory guidelines concerning GCP, questions have arisen as to how best RBM plans can comply. These questions and answers will assist sponsors in assuring compliance.

Aurinia Pharma has announced the selection of Worldwide Clinical Trials as its CRO for the AURORA study.

PAREXEL has announced the launch of its expanded Managed Access Programs service.

Examining the role of Clinical Research Malaysia in advancing industry-sponsored drug development in the country.

Clinerion has announced the release of its Patient Recruitment System Patient Finder tool for market access.

The 21st Century Cures Act, passed in December, contains provisions that many have questioned and criticized. This review of those provisions shows that progress in this sector is being made.